Literature DB >> 28064426

The impact of mode of presentation on distress in patients with early stage breast cancer.

L Jane McSweeney1, D O'Mahony2, J E Battley2,3, E Lee3, L Nagle2, S O'Reilly2,3.   

Abstract

AIMS: We set out to determine whether a difference exists between levels of psychological distress in women diagnosed with breast cancer through routine screening versus those who presented symptomatically.
METHODS: We assessed levels of distress in comparable numbers of patients with screen-detected and non-screen-detected female breast cancer patients being treated with curative intent, using the Hospital Anxiety and Distress Scale (HADS) (total n = 93).
RESULTS: In both cohorts, 50.5% scored above threshold for anxiety, depression, or both. Being aged over 60 was associated with concomitant positive anxiety and depression screening in both cohorts. Financial stress was associated with positive depression scores. No statistically significant difference was found between HADS scores for screen-detected versus self-detected patients.
CONCLUSION: Over 50% of patients with screen-detected or symptomatic breast cancer experience high levels of distress. Consideration should be made for the routine use of distress screening in this population.

Entities:  

Keywords:  Anxiety; Breast cancer; Depression; Distress; Screening

Mesh:

Year:  2017        PMID: 28064426     DOI: 10.1007/s11845-016-1543-2

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?

Authors:  A Hall; R A'Hern; L Fallowfield
Journal:  Eur J Cancer       Date:  1999-01       Impact factor: 9.162

2.  The role of socioeconomic status in adjustment after ductal carcinoma in situ.

Authors:  Janet S de Moor; Ann H Partridge; Eric P Winer; Jennifer Ligibel; Karen M Emmons
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

3.  Depression and anxiety in women with early breast cancer: five year observational cohort study.

Authors:  Caroline Burgess; Victoria Cornelius; Sharon Love; Jill Graham; Michael Richards; Amanda Ramirez
Journal:  BMJ       Date:  2005-02-04

4.  Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months.

Authors:  Lesley Stafford; Fiona Judd; Penny Gibson; Angela Komiti; G Bruce Mann; Michael Quinn
Journal:  Psychooncology       Date:  2013-02-12       Impact factor: 3.894

5.  Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer.

Authors:  C F Jehn; B Flath; A Strux; M Krebs; K Possinger; A Pezzutto; D Lüftner
Journal:  Breast Cancer Res Treat       Date:  2012-11-03       Impact factor: 4.872

6.  Predictive factors for psychological distress related to diagnosis of breast cancer.

Authors:  Tsuguo Iwatani; Ayako Matsuda; Hidetaka Kawabata; Daishu Miura; Eisuke Matsushima
Journal:  Psychooncology       Date:  2013-03       Impact factor: 3.894

7.  Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments.

Authors:  A M H Krebber; L M Buffart; G Kleijn; I C Riepma; R de Bree; C R Leemans; A Becker; J Brug; A van Straten; P Cuijpers; I M Verdonck-de Leeuw
Journal:  Psychooncology       Date:  2013-09-16       Impact factor: 3.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.